Mesothelioma Research Demonstrates Power of Intrapleural Immunotherapy
New metadata suggests that intrapleural immunotherapy is a powerful, targeted way to treat malignant pleural mesothelioma. Pleural mesothelioma is…
-
-
Asia | Immune Systems | Immunotherapy | International | Research | Treatments | Updates
New Mesothelioma Immunotherapy Treatment Reduces Tregs with Immunotoxin
There is a new mesothelioma immunotherapy treatment in the works. This one is based on reducing the number of Tregs… -
New Mesothelioma Drug Trial Begins
A new mesothelioma drug trial is now underway. The trial will test a brand new type of immunotherapy medication called… -
Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma
People with recurrent mesothelioma may get another chance at treatment with the immunotherapy drug avelumab. Malignant mesothelioma is highly resistant… -
Asia | Immunotherapy | International | Research | Treatments | Virus
Virotherapy for Mesothelioma Can Be More Effective
Hong Kong researchers may have found a way to get around one of the biggest challenges of virotherapy for mesothelioma.… -
Immunotherapy for Peritoneal Mesothelioma: New Drug Trial Begin
Researchers in Maryland and Missouri have started human testing of a new type of immunotherapy for peritoneal mesothelioma. If the… -
Radiation May Help Mesothelioma Immunotherapy Treatment Work Better
Hypofractionated radiation for mesothelioma could change how doctors treat this rare cancer. Researchers in Toronto, Canada have been testing hypofractionated… -
Chemotherapy | Europe | Immunotherapy | International | New Drugs | New Studies | Prognosis | Research | Surgery | Treatments
Study Predicts New Mesothelioma Therapies on the Horizon
A new article published by a pair of UK scientists predicts a brighter future for mesothelioma patients thanks to a… -
Asia | Immune Systems | Immunotherapy | International | New Drugs | Research | Treatments | Updates
Opdivo for Malignant Mesothelioma: Could a Lower Dose Work?
There is new evidence that low doses of the drug Opdivo (nivolumab) may extend lung cancer survival as well as… -
Immunotherapy Drug Produces ‘Exceptional and Sustained Response’ in Mesothelioma Patient
As part of what they call the “new era” of mesothelioma immunotherapy research, doctors in Ohio and Florida have just…
